Athira Pharma's ATH-1105 Shows Promise for ALS in Neuroscience Study | Mirage News

Retrieved on: 2024-02-08 21:15:48

Tags for this article:

Neurology

Neurochemistry

Rare diseases

Central nervous system

Athira Pharma

ALS

Neuroprotection

Neurodegenerative disease

Astrocyte

Neurotrophic factors

Hepatocyte growth factor

Neurotrophin mimetics

ATH

Athira Pharma Inc.

Click the tags to see associated articles and topics

Athira Pharma's ATH-1105 Shows Promise for ALS in Neuroscience Study | Mirage News. View article details on HISWAI: https://www.miragenews.com/athira-pharmas-ath-1105-shows-promise-for-als-1170623/

Excerpt

... Neuroscience. ATH-1105 is a next-generation, orally administered small molecule drug candidate designed to enhance the neurotrophic hepatocyte ...

Article found on: www.miragenews.com

View Original Article